Shockwave Medical, Inc. Common Stock
SWAV
SWAV was delisted on the 30th of May, 2024.
110 hedge funds and large institutions have $825M invested in Shockwave Medical, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 42 increasing their positions, 23 reducing their positions, and 26 closing their positions.
83% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 23
56% more call options, than puts
Call options by funds: $5.4M | Put options by funds: $3.45M
7% less funds holding
Funds holding: 118 → 110 (-8)
19% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 26
23% less capital invested
Capital invested by funds: $1.07B → $825M (-$250M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$33.7M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$28.9M |
| 3 |
AGM
Alpine Global Management
New York
|
+$23.8M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$15.6M |
| 5 |
JP Morgan Chase
New York
|
+$11.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$54.2M |
| 2 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$24.6M |
| 3 |
Millennium Management
New York
|
-$11.8M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$7.71M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$6.92M |
SWAV Hedge Fund Activity: Q1 2020 in Review
110 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Shockwave Medical, Inc. Common Stock (SWAV) for Q1 2020, worth a combined $825M — down 23% from $1.07B a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of SWAV and 21 opened new positions — a net loss of 5 holders — while 23 trimmed existing stakes and 42 added.
The largest buyer was Wells Fargo, adding an estimated $33.7M. The largest seller was T. Rowe Price Associates, cutting an estimated $54.2M.
- 110 institutional investors held Shockwave Medical, Inc. Common Stock (SWAV) as of Q1 2020, down from 118 in Q4 2019.
- Funds reported $825M of Shockwave Medical, Inc. Common Stock stock for Q1 2020, down 23% quarter-over-quarter.
- 21 funds opened new Shockwave Medical, Inc. Common Stock positions in Q1 2020 and 26 closed out, a net change of -5 holders.
- The largest Shockwave Medical, Inc. Common Stock buyer in Q1 2020 was Wells Fargo, an estimated $33.7M added.
- The largest Shockwave Medical, Inc. Common Stock seller in Q1 2020 was T. Rowe Price Associates, an estimated $54.2M sold.
Based on aggregated 13F filings for Q1 2020.